Haemonetics, a global provider of blood and plasma supplies and services, agreed to acquire Cardiva Medical, a manufacturer of vascular closure systems, for $510m, comprising of a $475m upfront payment in cash and $35m in contingent consideration based on sales growth. The acquisition is subject to customary closing conditions and is expected to be completed in the first quarter of calendar 2021. "We are excited to add Cardiva's vascular closure technology to our portfolio and look forward to welcoming their talented team. This acquisition immediately expands and diversifies our hospital offerings in the large and growing interventional cardiology and electrophysiology markets and aligns with our innovation agenda," Chris Simon, Haemonetics President and CEO.